Advanced search
Start date
Betweenand

HUMAN RECOMBINANT ENDOOLIGOPEPTIDASE A (hEOPA)

OfficeWIPO
Document type:Patent
Inventor(s): Antonio Carlos Martins De Camargo; Mirian Akemi Furuie Hayashi; Fernanda Calheta Vieira Portaro; Juliano Rodrigo Guerreiro
Applicant:Antonio Carlos Martins de Camargo; Fernanda Calheta Vieira Portaro; Guerreiro, Juliano; Mirian Akemi Furuie Hayashi
Year: 2003
Application Number:PCT/BR2003/000189
IPC: C12N 9/64
Abstract

This invention refers to a process for the determination of the primary structure of the mRNA coding for human endooligopeptidase A (hEOPA) and its protein sequence. In addition, the invention relates to a process for the determination of the structure of the hEOPA gene and the production of recombinant hEOPA. Furthermore, the invention relates to a process of generating antibodies against hEOPA in mice.


FAPESP's process: 95/02850-1 - Proteolytic processing of bioactive peptides and toxins
Grantee:Antonio Carlos Martins de Camargo
Principal Investigator:Antonio Carlos Martins de Camargo
Institution: Secretaria da Saúde (São Paulo - Estado). Instituto Butantan
Support Opportunities: Research Projects - Thematic Grants

Grantee:Mirian Akemi Furuie Hayashi
Principal Investigator:Mirian Akemi Furuie Hayashi
Institution: Secretaria da Saúde (São Paulo - Estado). Instituto Butantan
Support Opportunities: Research Grants - Support for Intellectual Property Rights and Licensing (PAPI/Nuplitec)